219 related articles for article (PubMed ID: 21907210)
1. Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes.
Zhou B; Honor LB; Ma Q; Oh JH; Lin RZ; Melero-Martin JM; von Gise A; Zhou P; Hu T; He L; Wu KH; Zhang H; Zhang Y; Pu WT
J Mol Cell Cardiol; 2012 Jan; 52(1):43-7. PubMed ID: 21907210
[TBL] [Abstract][Full Text] [Related]
2. No muscle for a damaged heart: thymosin beta 4 treatment after myocardial infarction does not induce myocardial differentiation of epicardial cells.
Kispert A
J Mol Cell Cardiol; 2012 Jan; 52(1):10-2. PubMed ID: 22019445
[No Abstract] [Full Text] [Related]
3. Thymosin β4 released from functionalized self-assembling peptide activates epicardium and enhances repair of infarcted myocardium.
Wang YL; Yu SN; Shen HR; Wang HJ; Wu XP; Wang QL; Zhou B; Tan YZ
Theranostics; 2021; 11(9):4262-4280. PubMed ID: 33754060
[TBL] [Abstract][Full Text] [Related]
4. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
[No Abstract] [Full Text] [Related]
5. Thymosin beta4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cell activation in adult mice in vivo.
Bock-Marquette I; Shrivastava S; Pipes GC; Thatcher JE; Blystone A; Shelton JM; Galindo CL; Melegh B; Srivastava D; Olson EN; DiMaio JM
J Mol Cell Cardiol; 2009 May; 46(5):728-38. PubMed ID: 19358334
[TBL] [Abstract][Full Text] [Related]
6. Thymosin β4: multiple functions in protection, repair and regeneration of the mammalian heart.
Bollini S; Riley PR; Smart N
Expert Opin Biol Ther; 2015; 15 Suppl 1():S163-74. PubMed ID: 26094634
[TBL] [Abstract][Full Text] [Related]
7. C-terminal variable AGES domain of Thymosin β4: the molecule's primary contribution in support of post-ischemic cardiac function and repair.
Hinkel R; Ball HL; DiMaio JM; Shrivastava S; Thatcher JE; Singh AN; Sun X; Faskerti G; Olson EN; Kupatt C; Bock-Marquette I
J Mol Cell Cardiol; 2015 Oct; 87():113-25. PubMed ID: 26255251
[TBL] [Abstract][Full Text] [Related]
8. Cardiac-specific overexpression of human stem cell factor promotes epicardial activation and arteriogenesis after myocardial infarction.
Xiang FL; Liu Y; Lu X; Jones DL; Feng Q
Circ Heart Fail; 2014 Sep; 7(5):831-42. PubMed ID: 25107671
[TBL] [Abstract][Full Text] [Related]
9. Thymosin β4 and cardiac regeneration: are we missing a beat?
Gajzer DC; Balbin J; Chaudhry HW
Stem Cell Rev Rep; 2013 Jun; 9(3):303-12. PubMed ID: 22628110
[TBL] [Abstract][Full Text] [Related]
10. Wt1 and epicardial fate mapping.
Rudat C; Kispert A
Circ Res; 2012 Jul; 111(2):165-9. PubMed ID: 22693350
[TBL] [Abstract][Full Text] [Related]
11. Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies.
Bock-Marquette I; Maar K; Maar S; Lippai B; Faskerti G; Gallyas F; Olson EN; Srivastava D
Int Immunopharmacol; 2023 Mar; 116():109741. PubMed ID: 36709593
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted microbubble delivery.
Chen S; Shimoda M; Chen J; Grayburn PA
Gene Ther; 2013 Feb; 20(2):225-33. PubMed ID: 23151517
[TBL] [Abstract][Full Text] [Related]
13. Re-activated adult epicardial progenitor cells are a heterogeneous population molecularly distinct from their embryonic counterparts.
Bollini S; Vieira JM; Howard S; Dubè KN; Balmer GM; Smart N; Riley PR
Stem Cells Dev; 2014 Aug; 23(15):1719-30. PubMed ID: 24702282
[TBL] [Abstract][Full Text] [Related]
14. The epicardium as a candidate for heart regeneration.
Smart N; Riley PR
Future Cardiol; 2012 Jan; 8(1):53-69. PubMed ID: 22185446
[TBL] [Abstract][Full Text] [Related]
15. Cardiac regeneration from activated epicardium.
van Wijk B; Gunst QD; Moorman AF; van den Hoff MJ
PLoS One; 2012; 7(9):e44692. PubMed ID: 23028582
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of thymosin β4 from injected collagen-chitosan hydrogels promotes angiogenesis and prevents tissue loss after myocardial infarction.
Chiu LL; Reis LA; Momen A; Radisic M
Regen Med; 2012 Jul; 7(4):523-33. PubMed ID: 22817626
[TBL] [Abstract][Full Text] [Related]
17. Cardiac repair with thymosin β4 and cardiac reprogramming factors.
Srivastava D; Ieda M; Fu J; Qian L
Ann N Y Acad Sci; 2012 Oct; 1270():66-72. PubMed ID: 23050819
[TBL] [Abstract][Full Text] [Related]
18. Multipotency and cardiomyogenic potential of human adipose-derived stem cells from epicardium, pericardium, and omentum.
Wystrychowski W; Patlolla B; Zhuge Y; Neofytou E; Robbins RC; Beygui RE
Stem Cell Res Ther; 2016 Jun; 7(1):84. PubMed ID: 27296220
[TBL] [Abstract][Full Text] [Related]
19. Epicardial SMARCA4 deletion exacerbates cardiac injury in myocardial infarction and is related to the inhibition of epicardial epithelial-mesenchymal transition.
Ma X; Zhao J; Feng Y
J Mol Cell Cardiol; 2024 Jun; 191():76-87. PubMed ID: 38718920
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell-loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium.
Wang QL; Wang HJ; Li ZH; Wang YL; Wu XP; Tan YZ
J Cell Mol Med; 2017 Sep; 21(9):1751-1766. PubMed ID: 28244640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
